DBV Technologies (DBVT) Share-based Compensation Growth (1y) (2021 - 2026)
DBV Technologies (DBVT) Share-based Compensation Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 118.32% |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -40.86% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 0.18% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 5,886.05% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | DBV Technologies | 267.50 Mn | 92.60 Mn | - | 208.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 208.33% |
| Mar 31, 2026 | 35.29% |
| Dec 31, 2025 | 524.72% |
| Sep 30, 2025 | -64.59% |
| Jun 30, 2025 | -21.31% |
| Mar 31, 2025 | -13.18% |
| Dec 31, 2024 | -137.16% |
| Sep 30, 2024 | 17.43% |
| Jun 30, 2024 | -15.93% |
| Mar 31, 2024 | 19.98% |
| Dec 31, 2023 | -24.29% |
| Sep 30, 2023 | 38.87% |
| Jun 30, 2023 | 68.27% |
| Mar 31, 2023 | 19.74% |
| Dec 31, 2022 | 268.41% |
| Sep 30, 2022 | -37.14% |
| Jun 30, 2022 | -1.46% |
| Mar 31, 2022 | -4.88% |
| Dec 31, 2021 | -152.10% |
| Sep 30, 2021 | 2,195.95% |